Expert Review of Neurotherapeutics

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	49
Where Art Thou O treatment for diabetic neuropathy: the sequel	49
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	43
The relevance of cortical thickness in migraine sufferers and implications to therapy	42
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	31
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	30
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	30
Steps to manage treatment-refractory migraine in adults	30
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	29
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	29
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	28
Advances in the treatment and management of frontotemporal dementia	28
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	27
The latest developments with internet-based psychological treatments for depression	26
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	26
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	25
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	25
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications	24
Why is ADHD so difficult to diagnose in older adults?	24
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	23
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	23
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	23
Hesitancies in primary headaches treatments	22
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	22
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?	22

Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	22
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	22
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	21
Advances in the early diagnosis of amyotrophic lateral sclerosis	21
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	21
Correction	20
Spinal automaticity of movement control and its role in recovering function after spinal injury	19
Preferences, tailoring, and self-tailoring in internet-delivered treatments: lessons learned	19
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	19
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	18
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	18
Current use of neurotoxins for alleviating symptoms of cervical dystonia	18
Mindfulness as a therapeutic option for obsessive-compulsive disorder	18
Virtual reality technology in the treatment of anxiety – progress and future challenges	18
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	18
Multimodal approaches to the treatment of personality disorder	17
Diagnostic advances and challenges in meningioma	17
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	17
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	17
The impact of sleep apnea on epilepsy treatment outcomes	17
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	16
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	16
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	16
The differential diagnosis of autism spectrum disorder in adults	16
Considerations for hormonal therapy in migraine patients: a critical review of current practice	16
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	15
Long-term outcomes in refractory status epilepticus	15
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	15
Cross-national reflections on medicinal cannabis and depression	15
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	15
Illuminating the way: the role of bright light therapy in the treatment of depression	15
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	15
A novel treatment option for intrajejunal levodopa administration	15
Daridorexant: exploring its role in the treatment of insomnia disorder	15
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	14
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	14
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	14
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor	14
Considering hearing loss as a modifiable risk factor for dementia	14
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	14
Frontotemporal dementia. How to deal with its diagnostic complexity?	14
Updated review of rescue treatments for seizure clusters and prolonged seizures	13
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	13
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	13
Could self-reporting sleep duration become an important tool in the prediction of dementia?	12
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	12
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	12
Do people with bipolar disorder have a greater risk of dementia in later life?	12
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	12

An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis	11
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	11
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	11
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	11
Therapeutic issues in Guillain–Barré syndrome	11
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	11
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	11
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?	11
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?	11
Developments in targeting calcitonin gene-related peptide	11
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”	10
Bipolar disorder staging and the impact it has on its management: an update	10
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	10
What place does daridorexant have in the treatment of Binge-Eating Disorder?	10
Long-term central nervous system (CNS) consequences of COVID-19 in children	10
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	10
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	10
Rethinking the role of trazodone in the different depressive dimensions	10
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	10
Stem cell therapy for patients with paraplegia: is there hope for the future?	10
When and in what patient segments are low-intensity and remote interventions valuable for treating symptoms of post-concussion syndrome?	10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	10
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	10
Deep brain stimulation: new programming algorithms and teleprogramming	9
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	9
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	9
Contemporary perspectives in cerebral amyloid angiopathy	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Tobacco use disorder and depression: emerging strategies and recommendations:	9
Learnings in developmental and epileptic encephalopathies: what do we know?	9
Exploring the differential diagnosis of generalized diabetic peripheral neuropathy	9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	9
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	9
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
The challenges and opportunities related to the therapeutic use of music in psychiatry	8
An update on pharmacotherapy for trigeminal neuralgia	8
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	8
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	8
The value of radiotherapy in patients with recurrent atypical meningioma: an update	8
Contemporary diagnosis and treatment of conduct disorder in youth	8
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	8
Is transcranial direct current stimulation a viable treatment option for fibromyalgia?	8
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	8
Letter to the editor: reflections on the future of medical cannabis research for depression	8
Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance	7
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	7
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	7
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	7
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	7
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	7
When is pharmacological intervention recommended for adults with social anxiety disorder?	7
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	7
Mobile health technologies for the management of Parkinson’s disease	7
Pharmacological strategies for treating social anxiety disorder in adults: a systematic review of studies published since 2015	7
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy	7
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	7
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	7
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	7
Current and emerging therapies for autoimmune encephalitis	7
What impact can brain stimulation interventions have on borderline personality disorder?	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	7
An update on the comorbidity of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) and its clinical management	7
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	7
Optimizing cognitive behavioral therapy to treat anxiety among youth with autism spectrum disorders	6
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	6
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	6
Speech and language outcome measures in clinical trials of Alzheimer’s and Parkinson’s diseases	6
Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison	6
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson’s disease: a systematic review of chronic randomized controlled trials	6
Is it possible to prevent relapse in panic disorder?	6
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	6
Pharmacological options for narcolepsy: are they the way forward?	6
Challenges in the treatment of dysthymia: a narrative review	6

Centanafadine to treat ADHD in children and adolescents: a plain language summary of publication	6
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	6
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	6
Assessing cognitive impairment among pediatric epilepsies: a systematic review	6
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Precision pain management: can delta opioid receptor (DOR) agonists outperform more traditional pain management strategies?	6
The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary	6
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	6
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	6
Paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury: the pathophysiological role of glutamate and potential treatment with branched-chain amino acids	6
Managing symptoms and improving the quality of life of persons with Machado-Joseph disease	6
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	6
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	6
Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions	5
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	5
Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway	5
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	5
Current perspectives on the diagnosis and management of acute transverse myelitis	5
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	5
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Rethinking the medication management of major depression	5
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	5
Delirium and dementia in the ICU - A neurocritical care perspective	5
Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage	5
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	5
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	5
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
Evaluating the adenosine hypothesis of restless legs syndrome and its implications for current and future treatment strategies	5
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	5
Acute and prophylactic treatment of dialysis headache: a systematic review	5
Are ketamine and its enantiomers the answer to treatment-refractory depression?	5
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
Redefining insomnia: from neural dysregulation to personalized therapeutics	4
Trichotillomania and its treatment: an updated review and recommendations	4
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
Current options for the treatment of anxiety in adults with autism spectrum disorder	4
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	4
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	4
Withdrawal of antiseizure medications – for whom, when, and how?	4
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
Current and emerging treatment options for Angelman syndrome	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Centanafadine for the treatment of attention-deficit/hyperactivity disorder in adults: a plain language summary of publication	4
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	4
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	4
Managing cognitive impairment in Parkinson’s disease: an update of the literature	4
Overcoming clinical challenges of refractory neuropathic pain	4
Essential tremor - drug treatments present and future	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
Can pharmacotherapy help to reduce trichotillomania?	4
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	4
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	4
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	4
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	4
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	4